DNA-Genentech Stock Research, Ratings, and Analysis

Genentech (dna) Stock Research

Last Updated by Anonymous | Update This Page Now

►Summary | Profile | News | Chart | SWOT | Cash Flow | Comps | Buffett | WACC

Company Description: Genentech, Inc. discovers and manufactures pharmaceutical products for the treatment of such diseases as colon cancer, non-Hodgkins lymphoma, breast cancer, age-related macular degeneration, asthma, growth hormone deficiency, heart attacks, blood clots, cystic fibrosis, and plaque psoriasis. The company collaborates with a number of research and pharmaceutical firms and sells products to specialty distributors and pharmacies. Update

Market Research Update

Health Care Industry Research & Analysis: The health care industry depends on the care of health-related services by professionals for the benefit of patients. Medical device markers, insurance companies, pharmaceutical drug developers and government institutions are major participants in the treatment of sick, injured and disabled patients. Health Care Trading Strategy: Health Care stocks tend to be less sensitive to economic changes. Look for undervalued health care investments at any point in the business cycle when stock prices are low. However, biotech, employment staffing and insurance companies may all decrease during recessions for different reasons. Government intervention is another important factor in health care investments, since government spending in health care is a very large portion of overall health care spending. When governments change spending plans, different sub-sectors in the industry are significantly affected. Upward sloping stock charts and financial news may indicate a selling opportunity while the opposite means that stocks are becoming undervalued.

Industry Sub Sector: .

Market Challenges: Opportunities: Solutions:

Strategy Analysis Update

Strategy: Genentech has a narrow focus that serves a particular customer niche with either a unique product or with a low cost advantage over competitors. (read more). Competitive Advantages:

Financial Analysis Update

Current Revenue Sources: Future Revenue Sources: